Eli Lilly’s Covid-19 drug bamlanivimab is no longer distributed in 3 states because of a variant, Woodcock says

Zachary Brennan

Senior Editor

The US government is no longer distributing Eli Lilly’s bamlanivimab into California, Arizona and Nevada because of the prevalence of a viral variant that is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Eli Lilly’s Covid-19 drug bamlanivimab is no longer distributed in 3 states because of a variant, Woodcock says

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

WuXi companies may sell units impacted by Biosecure — report

Exclusive: Relay Therapeutics cuts another 10% of company, citing continued streamlining efforts

Flagship partners with key Singapore R&D agency as it boosts APAC investment

End of obesity drug shortage threatens patient access to compounded shots that Lilly calls risky

Novo and Lilly outline plans to mitigate disruptions from US port strikes

3 Tiers for AAV Potency Assay Development Success

Eli Lil­ly’s Covid-19 drug bam­lanivimab is no longer dis­trib­uted in 3 states be­cause of a vari­ant, Wood­cock says

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Eli Lilly’s Covid-19 drug bamlanivimab is no longer distributed in 3 states because of a variant, Woodcock says